Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Tuesday, December 11, 2018 · 470,773,901 Articles · 3+ Million Readers

SENS Research Foundation Receives $1 Million Bitcoin Donation From Pineapple Fund

MOUNTAIN VIEW, Calif., Dec. 15, 2017 (GLOBE NEWSWIRE) -- SENS Research Foundation (SRF) announced today the receipt of a $1 million bitcoin donation from the Pineapple Fund.  The Pineapple Fund recently announced its commitment to donating $86 million in bitcoin to charities and causes around the world.

/EIN News/ -- “SENS Research Foundation is honored to be one of the recipients of the Pineapple Fund’s donations,” said Mike Kope, CEO, SENS Research Foundation.  “Our work to cure the diseases of aging is dependent on the generous support of our community.  Donations such as that of the Pineapple Fund will enable us to continue to support our research and education programs.”

To learn more and to donate to the SENS Research Foundation please go to www.sens.org.                                                                                                           

About SENS Research Foundation (SRF)
SENS Research Foundation is a 501(c)(3) nonprofit that works to research, develop, and promote comprehensive regenerative medicine solutions for the diseases of aging. SRF is focused on a damage repair paradigm for treating the diseases of aging, which it advances through scientific research, advocacy, and education. SENS Research Foundation supports research projects at universities and institutes around the world with the goal of curing such age-related diseases as macular degeneration, heart disease, cancer, and Alzheimer’s disease. Educating the public and training researchers to support a growing regenerative medicine field are also major endeavors of the organization that are being accomplished though advocacy campaigns and educational programs. For more information, visit www.sens.org.

Media Contact:
Jerri Barrett
jerri.barrett@sens.org

Powered by EIN News
Distribution channels: Healthcare & Pharmaceuticals Industry


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release